Post-partum Depression Clinical Trial
Official title:
Pilot Study on the Use of Acupuncture for Postpartum Depression
Verified date | January 2013 |
Source | The University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | Hong Kong: Department of Health |
Study type | Interventional |
The proposed study is a randomized controlled trial to examine the efficacy and safety of active acupuncture versus placebo acupuncture for the treatment of postpartum depression. The investigators hypothesis is that active acupuncture would be superior to placebo acupuncture in the short-term treatment of postpartum depression.
Status | Completed |
Enrollment | 20 |
Est. completion date | June 2012 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Ethnic Hong Kong Chinese aged 18 years or above; - Within 6 months of giving birth; - Edinburgh Postnatal Depression Scale (EPDS) (Cox et al., 1987) score higher than or equal to 12 or being diagnosed as depressed by their obstetrician; - Meeting the Diagnostic and Statistical Manual of Mental Disorders-IV diagnosis criteria for major depressive disorder; - 17-item Hamilton Depression Rating Scale (HDRS17) (Hamilton, 1960) score of between 12 and 19 at screening and baseline assessment; - Willingness to give informed consent and comply with trial protocol. Exclusion Criteria: - Suffering from other psychiatric disorders such as schizophrenia, other psychotic disorders, bipolar disorder or substance use disorder; - Serious physical illnesses or mental disorders due to a general medical condition which are judged by the investigator to render unsafe; - A significant risk of suicide according to the rating of HDRS17 item 3 (score higher than 2), i.e., presence of ideas or gesture of suicide; - A presence of idea of self-harming according to the rating of EPDS item 10 (score higher than 0); - A significant risk of infanticide according to the investigator assessment; - Any acupuncture treatment during the previous 12 months prior to baseline; - Valvular heart defects, bleeding disorders or taking anticoagulant drugs; - Infection or abscess close to the site of selected acupoints; - Herbal remedies or psychotropic drugs that are intended for depression are taken within the last 2 weeks prior to baseline or during the study. - Receiving counseling or psychological therapies at baseline or during the study; - Participation in any clinical trial within the previous 3 months prior to baseline; |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Hong Kong | Kwong Wah Hospital | Hong Kong | |
Hong Kong | Queen Mary Hospital | Hong Kong | |
Hong Kong | Tsan Yuk Hospital | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong | Hospital Authority, Hong Kong, Kwong Wah Hospital |
Hong Kong,
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6. — View Citation
HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 17-item Hamilton Depression Rating Scale | To assess Depressive symptoms | 8 weeks | Yes |
Secondary | Hospital Anxiety and Depression Scale (HADS) | To assess depression and anxiety | 8 weeks | No |
Secondary | Sheehan Disability Scale | To assess subjects' functioning in work/study, social life and family | 8 weeks | No |
Secondary | Clinical Global Impression Scale | To assess severity of illness and improvement due to treatment | 8 weeks | No |
Secondary | Edinburgh Postnatal Depression Scale | To assess subjective Depressive symptoms | 8 weeks | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05077644 -
Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD)
|
N/A | |
Active, not recruiting |
NCT03416010 -
Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women
|
N/A | |
Withdrawn |
NCT02738021 -
Managing PPD at Gouverneur
|
N/A | |
Recruiting |
NCT06208852 -
Virtual Patient Navigation During a Pandemic
|
N/A | |
Withdrawn |
NCT02741206 -
Preventing Postpartum Depression in Prenatal Care
|
N/A | |
Completed |
NCT00373750 -
Cradling Our Future Through Family Strengthening Study
|
N/A | |
Recruiting |
NCT05518162 -
Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
|
N/A | |
Not yet recruiting |
NCT06131255 -
DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")
|
||
Not yet recruiting |
NCT06285916 -
A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
|
Phase 2 | |
Completed |
NCT01407783 -
Systems of Care for New Moms: Integrating Depression Treatment
|
N/A |